Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial)
Saved in:
| Published in: | Discover Oncology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868666411008655360 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Discover Oncology |
| description | |
| discipline_display | Endocrinology |
| discipline_facet | Endocrinology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:94631 |
| institution | FRELIP |
| journal_source_facet | Discover Oncology |
| last_indexed | 2026-06-22T03:32:42.104Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial) Endocrinology General Endocrinology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Endocrinology General Endocrinology |
| subject_facet | Endocrinology General Endocrinology |
| title | Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial) |
| title_alt | Bevacizumab añadido a la quimioterapia de inducción convencional para niños con neuroblastoma de alto riesgo (ensayo BRAVEN) Bevacizumab ajouté à la chimiothérapie d'induction conventionnelle pour les enfants atteints de neuroblastome à haut risque (essai BRAVEN) Bevacizumabe adicionado à quimioterapia de indução convencional para crianças com neuroblastoma de alto risco (ensaio BRAVEN) |
| title_auth | Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial) |
| title_es_txt | Bevacizumab añadido a la quimioterapia de inducción convencional para niños con neuroblastoma de alto riesgo (ensayo BRAVEN) |
| title_fr_txt | Bevacizumab ajouté à la chimiothérapie d'induction conventionnelle pour les enfants atteints de neuroblastome à haut risque (essai BRAVEN) |
| title_full | Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial) |
| title_fullStr | Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial) |
| title_full_unstemmed | Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial) |
| title_pt_txt | Bevacizumabe adicionado à quimioterapia de indução convencional para crianças com neuroblastoma de alto risco (ensaio BRAVEN) |
| title_short | Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial) |
| title_sort | bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (braven trial) |
| topic | Endocrinology General Endocrinology |
| url | https://link.springer.com/article/10.1007/s12672-026-05462-7 |